Faculty of Medicine in Hradec Králové, Department of Pharmacology:
Dr. Martin Štěrba, Dr. Olga Lenčová, Dr. Michaela Adamcová, Dr. Yvona Mazurová – Cardiotoxicity of anticancer drugs using in vivo models, molecular cardiobiology, pharmacological cardioprotection
Faculty of Pharmacy in Hradec Králové:
Department of Organic and Bioorganic Chemistry
Dr. Jaroslav Roh – Development of potential cardioprotective agents
Department of Pharmaceutical Chemistry and Pharmaceutical Analysis:
Dr. Petra Štěrbová – Pharmaceutical analysis and pharmacokinetics of potential cardioprotective agents
Prof. Petr Zimčík, Dr. Veronika Nováková – Photodynamic therapy, development of novel photosenzitizers
2. Collaborations within the Czech Republic:
Institute of Physiology, Czech Academy of Sciences, Prague
Prof. František Kolář, Dr. Jan Neckář – Myocardial ischemia/reperfusion injury, cardioprotection
3. International Collaborations:
Newcastle University, U.K.
Prof. Caroline Austin - Role of topoisomerase 2β in anthracycline-induced cardiotoxicity
University of Sydney, Australia
Prof. Des R. Richardson – Development of novel iron-chelating agents, role of iron in cancer proliferation
Duke University, Durham, NC, U.S.A.
Prof. Katherine J. Franz – Oxidative stress-activated prochelators of iron
University at Buffalo, Buffalo, NY, U.S.A.
Dr. Jonathan F Lovell - Photodynamic therapy of cancer
Past collaborations:
University of Central Florida, FL, U.S.A.
Prof. Mark T. Muller - Role of topoisomerase 2β in anthracycline-induced cardiotoxicity
Maastricht University Medical Centre, The Netherlands
Prof. Aalt Bast – Anthracycline-induced cardiotoxicity
Institute for Cardiovascular Research, Free University Amsterdam, The Netherlands
Dr. René J.P. Musters, Dr. Christa Boer – in vitro cardiobiology
McGill University, Montreal, Canada
Prof. Prem Ponka - cardioprotective aroylhydrazone iron chelators